王 明誠

Medicine & Life Sciences

1. Angiotensin Receptor Antagonists 18%
2. Anti-Bacterial Agents 18%
3. Anti-Infective Agents 11%
4. Bacteremia 20%
5. Blood Pressure 20%
6. Carbapenems 14%
7. Catheters 12%
8. Cefepime 10%
9. Chronic Kidney Failure 36%
10. Chronic Renal Insufficiency 90%
11. Cohort Studies 17%
12. Community-Acquired Infections 22%
13. Compliance 17%
14. Continuous Ambulatory Peritoneal Dialysis 17%
15. Diabetes Mellitus 11%
16. Dialysis 12%
17. Escherichia coli 78%
18. Fluoroquinolones 15%
19. Genes 17%
20. IMP-8 enzyme 10%
21. Incidence 16%
22. Infections 33%
23. Kidney 58%
24. Microbial Drug Resistance 14%
25. Mortality 22%
26. Peritoneal Dialysis 59%
27. Peritonitis 46%
28. Plasmids 19%
29. Population 20%
30. Pyelonephritis 18%
31. Quinolones 14%
32. Renal Dialysis 44%
33. Type 1 Diabetes Mellitus 14%
34. University Hospitals 14%
35. Urinary Tract 12%
36. Urine 16%
37. Urolithiasis 13%
38. Uropathogenic Escherichia coli 26%
39. Virulence 27%
40. Virulence Factors 37%